Pancreatic Cancer Research

ResearcherNebraska Medical CenterActive in the last 2 years

Nirakar Rajbhandari

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-8756-0363; OpenAlex author ID A5087470289. Sources: OpenAlex.

Their work

Papers
7 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
36
Papers, trials and grants by year

2013: 1 paper · 2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: none · 2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: 2 papers · 2024: 1 paper · 2025: 1 paper

Papers 7

  1. MICAL2 Promotes Pancreatic Cancer Growth and Metastasis. Co-author DOI 10.1158/0008-5472.can-24-0744↗
  2. The Janus kinase 1 is critical for pancreatic cancer initiation and progression. Co-author DOI 10.1016/j.celrep.2024.114202↗
  3. Single-cell mapping identifies MSI+ cells as a common origin for diverse subtypes of pancreatic cancer. Co-author DOI 10.1016/j.ccell.2023.09.008↗
  4. Smarcd3 is an epigenetic modulator of the metabolic landscape in pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41467-023-35796-7↗
  5. A Multiscale Map of the Stem Cell State in Pancreatic Adenocarcinoma. Co-author DOI 10.1016/j.cell.2019.03.010↗
  6. Cancer cell dormancy in novel mouse models for reversible pancreatic cancer: a lingering challenge in the development of targeted therapies. First author DOI 10.1158/0008-5472.can-13-3437↗
  7. Dormant cancer cells contribute to residual disease in a model of reversible pancreatic cancer. First author DOI 10.1158/0008-5472.can-12-2067↗

Closest collaborators

The 25 strongest of 36 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Andrew M. Lowy · 4 shared papers, 2019–2025 · strength 0.50
  2. Nikki K. Lytle · 3 shared papers, 2019–2023 · strength 0.33
  3. Lesley Paige Ferguson · 3 shared papers, 2019–2023 · strength 0.33
  4. Tannishtha Reya · 3 shared papers, 2019–2023 · strength 0.33
  5. Kay‐Uwe Wagner · 3 shared papers, 2013–2024 · strength 0.28
  6. Martin Wartenberg · 2 shared papers, 2019–2023 · strength 0.20
  7. José A. Galván · 2 shared papers, 2019–2023 · strength 0.20
  8. Eva Karamitopoulou · 2 shared papers, 2019–2023 · strength 0.20
  9. Raymond G. Fox · 2 shared papers, 2019–2023 · strength 0.20
  10. Haiyong Han · 2 shared papers, 2019–2023 · strength 0.20
  11. Daniel D. Von Hoff · 2 shared papers, 2019–2023 · strength 0.20
  12. Hridaya Shrestha · 1 shared paper, 2024 · strength 0.18
  13. Rayane Dennaoui · 1 shared paper, 2024 · strength 0.18
  14. Dieter Saur · 1 shared paper, 2024 · strength 0.18
  15. Divya Sood · 1 shared paper, 2025 · strength 0.17
  16. Bharti Garg · 1 shared paper, 2025 · strength 0.17
  17. Pnina Brodt · 1 shared paper, 2025 · strength 0.17
  18. Kevin Christian Montecillo Gulay · 1 shared paper, 2025 · strength 0.17
  19. Dawn Jaquish · 1 shared paper, 2025 · strength 0.17
  20. Cosimo Commisso · 1 shared paper, 2025 · strength 0.17
  21. Steve Gallinger · 1 shared paper, 2025 · strength 0.17
  22. Hervé Tiriac · 1 shared paper, 2025 · strength 0.17
  23. Derek Cridebring · 1 shared paper, 2023 · strength 0.13
  24. Jun Wang · 1 shared paper, 2023 · strength 0.13
  25. Michael Goggins · 1 shared paper, 2023 · strength 0.13

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.